◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Portfolio Building Block World Pharma And Biotech Index ETF (PBPH) ETF Overview

Name: Portfolio Building Block World Pharma And Biotech Index ETF (PBPH) price history and fund statistics
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Price history, fund statistics and profile — an exchange-traded fund.

Exchange-Traded Funds · Health · DATA UPDATED 2026-08-31

Portfolio Building Block World Pharma And Biotech Index ETF (PBPH) is an exchange-traded fund managed by Portfolio Building Block ETFs in the "Health" category. It manages roughly $952 million in assets.

The fund uses a “passive management” approach to track the performance, before fees and expenses, of the index.

Interactive chart & fund stats →

PBPH Fund Statistics

Expense ratio	0.13%
Assets under management	$952 million
Fund category	Health
Fund family	Portfolio Building Block ETFs
Inception	2025-11-25

The live price chart, fund profile and news are in the interactive PBPH viewer.

Other Companies in Health

IHE · iShares U.S. Pharmaceuticals ETF — $2 billion
ARKG · ARK Genomic Revolution ETF — $2 billion
IHF · iShares U.S. Healthcare Providers ETF — $1 billion
FXH · First Trust Health Care AlphaDEX Fund — $1 billion
PPH · VanEck Pharmaceutical ETF — $926 million
FTXH · First Trust Nasdaq Pharmaceuticals ETF — $911 million
RSPH · Invesco S&P 500 Equal Weight Health Care ETF — $769 million
XPH · State Street SPDR S&P Pharmaceuticals ETF — $489 million

← PBP All “P” companies PBQQ →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.